United States · FDA National Drug Code directory
Cinryze
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42227-081_421ea216-278f-4ca8-ae5d-5dafe85658a0
- Product NDC
- 42227-081
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- HUMAN C1-ESTERASE INHIBITOR
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20081201
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN C1-ESTERASE INHIBITOR — 500 [iU]/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) · 42227-081-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →